Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) EV to EBITDA (2021 - 2023)

Updated

Moderna's EV to EBITDA came in at 43.19 for Q2 2023, compared with 3.02 a year earlier and up 346.4% from the prior quarter.

Analysis

Moderna (MRNA) EV to EBITDA (2021 - 2023) Analysis & Trends

Over the trailing twelve months to Jun 30, 2023, Moderna reported EV to EBITDA of 12.17, up 957.2% year-over-year; for FY2022, it was 6.07, down 10.4% from FY2021.

  • Going back by year, EV to EBITDA was 6.77 in FY2021.
  • The Q2 2023 figure represents the highest quarterly EV to EBITDA since Q1 2021.
  • Year-over-year, EV to EBITDA increased in 1 of the last five quarters, with an average decline of 20.9%.
  • Business Quant data shows MRNA's EV to EBITDA at 9.67 (Q1 2023), 6.07 (Q4 2022) and 2.75 (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 43.19
Mar 31, 2023 9.67
Dec 31, 2022 6.07
Sep 30, 2022 2.75
Jun 30, 2022 3.02
Mar 31, 2022 3.55
Dec 31, 2021 6.77
Sep 30, 2021 18.91
Jun 30, 2021 22.14
Mar 31, 2021 66.63
API Access

Moderna EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MRNA&period=max&api_key=YOUR_API_KEY